Premenstrual disorders: Prevalence, etiology and impact

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 51, Issue 4, 2006, Pages 339-347

  Winer, Sharon A ^a,b   Rapkin, Andrea J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Depression; Menstrual cycle; Premenstrual dysphoric disorder; Premenstrual syndrome

Indexed keywords

NEUROHORMONE; NEUROTRANSMITTER; SEX HORMONE;

DISEASE SEVERITY; FEMALE; GENETIC PREDISPOSITION; HORMONE RESPONSE; HUMAN; MENSTRUAL CYCLE; PREMENSTRUAL SYNDROME; PREVALENCE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; UNITED STATES;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GONADAL HORMONES; HUMANS; LUTEAL PHASE; MENSTRUAL CYCLE; NEUROTRANSMITTER AGENTS; PREMENSTRUAL SYNDROME; QUALITY OF LIFE;

EID: 33646420097     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Frank RT: The hormonal basis of premenstrual tension. Arch Neurol Psychiatry 1931;26:1053-1057
2. Greene R, Dalton K: The premenstrual syndrome. Br Med J 1953;1:1007-1014
3. Ginsburg KA, Dinsay R: Premenstrual syndrome. In Practical Strategies in Obstetrics and Gynecology. Edited by SB Ransom. Philadelphia, WB Saunders, 2000, pp 684-694
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, text revision. Washington, DC, APA, 2000, pp 771-774
5. American College of Obstetricians and Gynecologists: Premenstrual syndrome. Obstet Gynecol 2000;95
6. Campbell EM, Peterkin D, O'Grady K, et al: Premenstrual symptoms in general practice patients: Prevalence and treatment. J Reprod Med 1997;42:637-646
7. Sternfeld B, Swindle R, Chawla A, et al: Severity of premenstrual symptoms in a health maintenance organization population. Obstet Gynecol 2002;99:1014-1024
8. Halbreich U, Monacelli E: Some clues to the etiology of premenstrual syndrome/premenstrual dysphoric disorder. Prim Psychiatry 2004;11:33-40
9. Kendler KS, Karkowski LM, Corey LA, et al: Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry 1998;155:1234-1240
10. Halbreich U: The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology (suppl 3) 2003;28:55-99
11. Bancroft J, Rennie D, Wamer P: Vulnerability to perimenstrual mood change: The relevance of a past history of depressive disorder. Psychosom Med 1994;56:225-231
12. Yonkers KA: The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry (suppl 15) 1997;58:19-25
13. Halbreich U: Menstrually related disorders: What we do know, what we only believe that we know, and what we know that we do not know. Crit Rev Neurobiol 1995;9:163-175
14. Critchlow DG, Bond AJ, Wingrove J: Mood disorder history and personality assessment in premenstrual dysphoric disorder. J Clin Psychiatry 2001;62:688-693
15. Björn I, Bixo M, Nojd KS, et al: Negative mood changes during hormone replacement therapy: A comparison between two progestogens. Am J Obstet Gynecol 2000;183:1419-1426
16. Speroff L, Fritz MA: Regulation of the menstrual cycle. In Clinical Gynecologic Endocrinology and Infertility. Seventh edition. Philadelphia, Lippincott Williams & Wilkins, 2005, pp 187-231
17. Facchinetti F, Genazzani AD, Martignoni E, et al: Neuroendocrine changes in luteal function in patients with premenstrual syndrome. J Clin Endocrinol Metab 1993;76:1123-1127
18. Steiner M, Pearlstein T: Premenstrual dysphoria and the serotonin system: Pathophysiology and treatment. J Clin Psychiatry 2000;61:17-21
19. Smith MJ, Adams LF, Schmidt PJ, et al: Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biol Psychiatry 2003;54:757-762
20. Schmidt PJ, Nieman LK, Danaceau MA, et al: Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998; 338:209-216
21. Joffe H, Cohen LS: Estrogen, serotonin, and mood disturbance: Where is the therapeutic bridge? Biol Psychiatry 1998; 44:798-811
22. Backstrom T, Sanders D, Leask R, et al: Mood, sexuality, hormones, and the menstrual cycle: II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom Med 1983;45:503-507
23. Halbreich U, Endicott J, Goldstein S, et al: Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 1986;74:576-586
24. Rubinow DR, Hoban MC, Grover GN, et al: Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol 1988;158:5-11
25. Smith SS, Gong QH, Hsu FC, et al: GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998;392:926-930
26. Rapkin AJ, Morgan M, Goldman L, et al: Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 1997;90:709-714
27. Monteleone P, Luisi S, Tonetti A, et al: Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 2000;142:269-273
28. Backstrom T, Andersson A, Andree L, et al: Pathogenesis in menstrual cycle-linked CNS disorders. Ann N Y Acad Sci 2003;1007:42-53
29. Sundstrom Poromaa I, Smith S, Gulinello M: GABA receptors, progesterone and premenstrual dysphoric disorder. Arch Women Ment Health 2003;6:23-41
30. Stoffel-Wagner B: Neurosteroid biosynthesis in the human brain and its clinical implications. Ann N Y Acad Sci 2003; 1007:64-78
31. Griffin LD, Conrad SC, Mellon SH: Current perspectives on the role of neurosteroids in PMS and depression. Int Rev Neurobiol 2001;46:479-492
32. Epperson CN, Haga K, Mason GF, et al: Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: A proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2002;59:851-858
33. Freeman EW, Frye CA, Rickels K, et al: Allopregnanolone levels and symptom improvement in severe premenstrual syndrome. J Clin Psychopharmacol 2002;22:516-520
34. Schmidt PJ, Purdy RH, Moore PH Jr, et al: Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 1994;79:1256-1260
35. Fink G, Sumner BE, Rosie R, et al: Estrogen control of central neurotransmission: Effect on mood, mental state, and memory. Cell Mol Neurobiol 1996;16:325-344
36. Rapkin AJ, Edelmuth E, Chang LC, et al: Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 1987;70: 533-537
37. Oelkers W: Drospirenone, a progestogen with antimineralocorticoid properties: A short review. Mol Cell Endocrinol 2004;217:255-261
38. Davidson BJ, Rea CD, Valenzuela GJ: Atrial natriuretic peptide, plasma renin activity, and aldosterone in women on estrogen therapy and with premenstrual syndrome. Fertil Steril 1988;50:743-746
39. Rosenstein DL, Kalogeras KT, Kalafut M, et al: Peripheral measures of arginine vasopressin, atrial natriuretic peptide and adrenocorticotropic hormone in premenstrual syndrome. Psychoneuroendocrinology 1996;21:347-359
40. Halbreich U, Borenstein J, Pearlstein T, et al: The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology (suppl 3) 2003;28:1-23
41. Hylan TR, Sundell K, Judge R: The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: Experience from the United States, United Kingdom, and France. J Womens Health Gend Based Med 1999;8:1043-1052
42. Borenstein JE, Dean BB, Endicott J, et al: Health and economic impact of the premenstrual syndrome. J Reprod Med 2003;48:515-524
43. Dean BB, Borenstein JE: A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome. J Occup Environ Med 2004;46:649-656
44. Borenstein J, Chiou CF, Dean B, et al: Estimating direct and indirect costs of premenstrual syndrome. J Occup Environ Med 2005;47:26-33